Endocrinology, Vol 127, 1941-1947, Copyright © 1990 by Endocrine Society

ARTICLES

The production of transforming growth factor-beta by chick growth plate chondrocytes in short term monolayer culture

DE Gelb, RN Rosier and JE Puzas
Department of Orthopedics, University of Rochester Medical Center, New York 14642.

Transforming growth factor-beta (TGF beta) is capable of regulating the proliferation and phenotypic expression of growth plate chondrocytes in culture. Chondrocytes were isolated from the growth plates from the long bones of 3- to 5-week-old chicks. Conditioned medium was harvested from short term monolayer cultures for the assay of TGF beta production by these cells. A receptor competition assay using [125I]TGF beta was used to quantitate the amount of TGF beta in the conditioned medium. Acid-activated conditioned medium contained 5.0 +/- 0.4 ng/ml TGF beta, while conditioned medium that had not been exposed to acid had undetectable levels of the peptide by this assay. The initial cell plating density was inversely related to the amount of TGF beta produced on a per cell basis. Growth plate chondrocytes separated by countercurrent centrifugal elutriation into maturationally distinct subpopulations had different rates of TGF beta production; hypertropic chondrocytes produced significantly more TGF beta (4.5 ng/10(6) cells) than the smallest chondrocytes isolated (2.3 ng/10(6) cells). A variety of other growth mediators were tested for their ability to influence TGF beta production by chondrocytes, and it was found that only basic fibroblast growth factor could significantly influence TGF beta production, producing a 6-fold increase in TGF beta recovered in the conditioned medium. The production of TGF beta by growth plate chondrocytes implicates it as an important autocrine or paracrine regulator in the process of endochondral calcification.

This article has been cited by other articles:

				J. T. K. Melton, N. M.P. Clarke, and H. I. Roach Matrix Metalloproteinase-9 Induces the Formation of Cartilage Canals in the Chondroepiphysis of the Neonatal Rabbit J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 155 - 161. [Abstract] [Full Text] [PDF]

				Y. Macotela, M. B. Aguilar, J. Guzman-Morales, J. C. Rivera, C. Zermeno, F. Lopez-Barrera, G. Nava, C. Lavalle, G. M. de la Escalera, and C. Clapp Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin J. Cell Sci., May 1, 2006; 119(9): 1790 - 1800. [Abstract] [Full Text] [PDF]

				Y. Nakamichi, C. Shukunami, T. Yamada, K.-i. Aihara, H. Kawano, T. Sato, Y. Nishizaki, Y. Yamamoto, M. Shindo, K. Yoshimura, et al. Chondromodulin I Is a Bone Remodeling Factor Mol. Cell. Biol., January 15, 2003; 23(2): 636 - 644. [Abstract] [Full Text] [PDF]

				H. A. Pedrozo, Z. Schwartz, M. Robinson, R. Gomez, D. D. Dean, L. F. Bonewald, and B. D. Boyan Potential Mechanisms for the Plasmin-Mediated Release and Activation of Latent Transforming Growth Factor-{beta}1 from the Extracellular Matrix of Growth Plate Chondrocytes Endocrinology, December 1, 1999; 140(12): 5806 - 5816. [Abstract] [Full Text]

				Z. Schwartz, V. L. Sylvia, D. D. Dean, and B. D. Boyan The Synergistic Effects of Vitamin D Metabolites and Transforming Growth Factor-{beta} on Costochondral Chondrocytes Are Mediated by Increases in Protein Kinase C Activity Involving Two Separate Pathways Endocrinology, February 1, 1998; 139(2): 534 - 545. [Abstract] [Full Text] [PDF]

				Y. Hiraki, H. Inoue, K.-i. Iyama, A. Kamizono, M. Ochiai, C. Shukunami, S. Iijima, F. Suzuki, and J. Kondo Identification of Chondromodulin I as a Novel Endothelial Cell Growth Inhibitor. PURIFICATION AND ITS LOCALIZATION IN THE AVASCULAR ZONE OF EPIPHYSEAL CARTILAGE J. Biol. Chem., December 19, 1997; 272(51): 32419 - 32426. [Abstract] [Full Text] [PDF]

				G. Del Giudice and M. K. Crow Review: Role of Transforming Growth Factor Beta (TGF{beta}) in Systemic Autoimmunity Lupus, August 1, 1993; 2(4): 213 - 220. [Abstract] [PDF]